+34 620 10 75 37info@nanbiosis.com

Nanbiosis

U6-S01. Use of High-pressure laboratory-scale plant

Use of High-pressure laboratory-scale plant

with 50, 100 and 300 mL reactors for the processing of biomaterials. Processing of cytotoxic compounds when required.

Preparation of soft molecular materials with controlled structure at supramolecular, micro- and nanoscopic level, using one-step methodologies based on green compressed fluids (i.e. compressed and supercritical CO2).Micro- and nanoparticulate single compounds with high supramolecular homogeneity (i.e., pure polymorphic phases, materials with single polymer folding, etc.).

  • Particulate polymeric matrix uniformly loaded with active compounds (therapeutics, cosmetic ingredients, catalyst, pigments, and dyes, etc.)
  • Dispersed systems (suspensions, liposomes, emulsions, vesicles) with narrow particle size distribution and high morphological homogeneity.
  • Porous materials, either crystalline or amorphous, with defined porosity and porous size.

Customer benefits

Lab-scale high pressure systems, based on a 50 mL, a 100 mL and a 300 mL stirred high pressure autoclaves equipped with pumps for the supply of compressed fluids and liquid solutions. The high-pressure systems can also optionally be equipped with several filters, manometers, thermocouples, and back pressure regulators. The maximum operative pressure is 23 MPa and the maximum operative temperature is 200 °C.
The 300 mL system is also equipped with a mass flowmeter, and a data acquisition system.
All the plants have been designed for micro- and nanostructuring molecular and soft materials.

Target customer

  • Pharmaceutical industry
  • Food Industry
  • Chemical industry
  • Materials research centers

References

Read More

U3-S02. Post synthesis peptide modification (On-site&Remote) OUTSTANDING

Post synthesis peptide modification (On-site&Remote) OUTSTANDING

Post-synthesis peptide modification such as:
– Cyclization through a disulphide bridge, amide, ester, thiosester, thioether, or various staple bonds.
– Biotinylation and/or incorporation of various imaging probes at the N-terminus, C-terminus or on some amino acid side chains (Lys, Cys…).
– Convenient peptide derivatisation for further conjugation by introducing a maleimide, succinimidyl, alkyne or azide-containing spacers.
– Peptide conjugation to polymers, proteins, probes and small molecules.
Multivalent peptide presentation molecules.

Customer benefits

  • Extensive experience in the synthesis of cyclic peptides (disulfide bridge, lactam, lactone, thioester, thioether).
  • Extensive experience in the synthesis of stapled peptides
  • Development of several peptide cyclization methods.
  • Extensive experience in the derivatisation of peptides for conjugation and attachment to various types of molecules (nanoparticles, polymers, imaging probes, small molecules).
  • Development of various strategies for the introduction of post-synthesis modifications.
  • Development of conjugation methodology.
  • Development of methodology for the generation of multivalent peptide presentation molecules.

Target customer

  • Research groups (drug delivery, molecular biology, pharmacology, nanotechnology, biotechnology)
  • Companies (biotech and pharma companies).

References

  • Direct Quantitative Immunochemical Analysis of Autoinducer Peptide IV for Diagnosing and Stratifying Staphylococcus aureus Infections. Montagut, Enrique-J.; Acosta, Gerardo; Albericio, Fernando; Royo, Miriam; Godoy-Tena, Gerard; Lacoma, Alicia ; Prat, Cristina ; Salvador, Juan-Pablo; Marco, Maria-Pilar. ACS Infectious Diseases (2022), 8, 645-656.
  • Hierarchical Quatsome-RGD Nanoarchitectonic Surfaces for Enhanced Integrin-Mediated Cell Adhesion. Martinez-Miguel, Marc; Castellote-Borrell, Miquel; Kober, Mariana; Kyvik, Adriana R. ; Tomsen-Melero, Judit ; Vargas-Nadal, Guillem; Munoz, Jose; Pulido, Daniel ; Cristobal-Lecina, Edgar; Passemard, Solene; oyo, Miriam ; Mas-Torrent, Marta ; Veciana, Jaume ; Giannotti, Marina I. ; Guasch, Judith ; Ventosa, Nora ; Ratera, Imma. ACS Applied Materials & Interfaces (2022), 14, 48179-48193.
  • Engineering a Nanostructured Nucleolin-Binding Peptide for Intracellular Drug Delivery in Triple-Negative Breast Cancer Stem Cells. Pesarrodona, Mireia; Sanchez-Garcia, Laura; Seras-Franzoso, Joaquin; Sanchez-Chardi, Alejandro; Balta-Foix, Ricardo; Camara-Sanchez, Patricia; Gener, Petra; Jara, Jose Juan; Pulido, Daniel ; Serna, Naroa; Schwartz, Simo; Royo, Miriam ; Villaverde, Antonio; Abasolo, Ibane ; Vazquez, Esther. ACS Applied Materials & Interfaces (2020), 12, 5381-5388.
  • Synthesis of Stable Cholesteryl-Polyethylene Glycol-Peptide Conjugates with Non-Disperse Polyethylene Glycol Lengths. Cristobal-Lecina, Edgar; Pulido, Daniel; Martin-Malpartida, Pau; Macias, Maria J.; Albericio, Fernando; Royo, Miriam. ACS Omega (2020), 5, 5508-5519.
  • Highly Versatile Polyelectrolyte Complexes for Improving the Enzyme Replacement Therapy of Lysosomal Storage Disorders. Giannotti, Marina I.; Abasolo, Ibane; Oliva, Mireia; Andrade, Fernanda; Garcia-Aranda, Natalia; Melgarejo, Marta; Pulido, Daniel; Corchero, Jose L.; Fernandez, Yolanda; Villaverde, Antonio; Royo, Miriam; Garcia-Parajo, Maria F.; Sanz, Fausto; Schwartz, Simo. ACS Applied Materials & Interfaces (2016), 8(39), 25741-25752.
  • Gated mesoporous silica nanoparticles using a double-role circular peptide for the controlled and target-preferential release of doxorubicin in CXCR4-expressing lymphoma cells. de la Torre, Cristina; Casanova, Isolda; Acosta, Gerardo; Coll, Carmen; Moreno, Maria Jose; Albericio, Fernando; Aznar, Elena; Mangues, Ramon; Royo, Miriam; Sancenon, Felix; Martinez-Manez, Ramon. Advanced Functional Materials (2015), 25, 687-695.
  • Multivalent dendrimers presenting spatially controlled clusters of binding epitopes in thermoresponsive hyaluronan hydrogels. Seelbach, Ryan J.; Fransen, Peter; Peroglio, Marianna; Pulido, Daniel; Lopez-Chicon, Patricia; Duttenhoefer, Fabian ; Sauerbier, Sebastian; Freiman, Thomas; Niemeyer, Philipp; Semino, Carlos; Albericio, Fernando; Alini, Mauro; Royo, Miriam; Mata, Alvaro; Eglin, David. Acta Biomaterialia (2014), 10, 4340-4350
  • Triazene as a powerful tool for solid-phase derivatization of phenylalanine containing peptides: Zygosporamide analogues as a proof of concept. Torres-Garcia, Carolina; Pulido, Daniel; Albericio, Fernando; Royo, Miriam; Nicolas, Ernesto. Journal of Organic Chemistry (2014), 79(23), 11409-11415.

3. Peptides-System for acidolactic cleavage of the peptide resin boundby anhydrous HF
Read More

U3-S01. Synthesis of peptides and characterisation (On-site&Remote) OUTSTANDING

Synthesis of peptides and characterisation (On-site&Remote) OUTSTANDING

Peptide production on various scales from mg (scale: 10 mg, 50 mg and 100 mg) and grams.
Synthesis of peptides containing phosphorylated amino acids, acylated or methylated side chains (lysine) or non-natural amino acids.
Peptides can be delivered as synthesis crudes (without purification) and purified (≥95% by HPLC).
Peptides are characterized by HPLC and HPLC-MS

Customer benefits

  • Extensive experience on peptide synthesis.
  • Experience in difficult sequences.
  • Control quality at different synthesis points.
  • Capability to design diverse synthesis strategies and purification
  • Development of peptide synthesis methodology.

Target customer

  • Research groups (drug delivery, molecular biology, pharmacology, nanotechnology, biotechnology)
  • Companies (biotech and pharma companies).

References

  • Pharmacological activation of insulin-degrading enzyme improves insulin secretion and glucose tolerance in diet-induced obese mice. Sanz-Gonzalez, Alba; Cozar-Castellano, Irene; Broca, Christophe ; Sabatier, Julia; Acosta, Gerardo A. ; Royo, Miriam ; Hernando-Munoz, Carla; Torroba, Tomas ; Perdomo, German ; Merino, Beatriz. Diabetes, Obesity and Metabolism (2023), 25, 3268-3278.
  • Amide Formation: Choosing the Safer Carbodiimide in Combination with OxymaPure to Avoid HCN Release. Manne, Srinivasa Rao; Luna, Omar; Acosta, Gerardo A.; Royo, Miriam ; El-Faham, Ayman ; Orosz, Gyorgy; de la Torre, Beatriz G. ; Albericio, Fernando. Organic Letters (2021), 23, 6900-6904.
  • Carbosilane Dendron-Peptide Nanoconjugates as Antimicrobial Agents
  • By: Fernandez, Jael; Acosta, Gerardo; Pulido, Daniel; Maly, Marek; Copa-Patino, Jose L.; Soliveri, Juan; Royo, Miriam; Gomez, Rafael; Albericio, Fernando; Ortega, Paula; de la Mata, F. Javier. Molecular Pharmaceutics (2019), 16, 2661-2674.
  • Optimized Stepwise Synthesis of the API Liraglutide Using BAL Resin and Pseudoprolines. Carbajo, Daniel; El-Faham, Ayman; Royo, Miriam; Albericio, Fernando. ACS Omega (2019), 4, 8674-8680
Read More

U2-S01. Scientific and technical support

Scientific and technical support

The scientific and technical support service provides valuable assistance to researchers and organizations in various aspects:

  • Immunogen Design: Expert advice on designing effective immunogens for antibody production.
  • ­Immunoreagent Synthesis and Production: Guidance on synthesizing and producing immunoreagents, including monoclonal and polyclonal antibodies.
  • Antibody Production: Support for generating high-quality antibodies for research purposes.
  • Immunoassay Design and Development: Customized development of immunoassays, including assay format design, sample matrix considerations, and sensitivity optimization.

The technical support provided is focused on identifying suitable immunogens for antibody production with desired characteristics for the user, while in the antibody production section, support is oriented towards designing screening methods during monoclonal antibody development to search for hybridomas with the desired specificity and sensitivity characteristics for each user.

Customer benefits

  • Scientific Expertise: Access to specialized knowledge in immunology and immunochemistry.
  • Technical Guidance: Assistance in experimental design, troubleshooting and optimization.
  • Cost-Effective Solutions: Avoiding the need to establish in-house facilities for antibody production and immunoassay development.
  • Accelerated Research: Faster progress due to expert support and streamlined processes.
  • ISO 9001 Certification: The development and production of monoclonal antibodies is backed by the ISO 9001:2015 certification, ensuring quality, reliability and adherence to international standards.

Target customer

Scientific and Technical Support Serviceis essential for organizations involved in Research and Development (R&D) across fields such as food safety and environmental control,  biomedicine, diagnostics, drug discovery, and therapeutic development.

Additional information

Selected references:

  • B. Rodriguez-Urretavizcaya, N. Pascual, C. Pastells, M. T. Martin-Gomez, Ll. Vilaplana, M.-P. Marco. Diagnostic and Stratification of Pseudomonas aeruginosa Infected Patients by Immunochemical Quantitative Determination of Pyocyanin from Clinical Bacterial Isolates. Frontiers in Cell. Infect. Microbiol., 11, 786929, 2021. DOI: 10.3389/fcimb.2021.786929. URL
  • Giovanna Roncador; Pablo Engel; Lorena Maestre; et al; Alison H.Banham., Nuria Pascual 2016. The European antibody network’s practical guide to finding and validating suitable antibodies for research. mAbs. Taylor & Francis Online. 8-1, pp.27-36.
  • Carme Pastells; Gerardo Acosta; Nuria Pascual; Fernando Albericio, Miriam Royo; M.-Pilar Marco. 2015. An immunochemical strategy based on peptidoglycan synthetic peptide epitopes to diagnose Staphylococcus aureus infections. Analytica Chimica Acta. Elsevier. 889, pp.203-211
Read More

U6-E10. Nanosight NS-300 for Nanoparticle Tracking Analysis by fluorescence mode

Nanosight NS300; Malvern Instruments

Descripción: Automated analysis of the size distribution and concentration

The Malvern NanoSight NS300 uses the technology of Nanoparticle Tracking Analysis (NTA). This unique technology utilizes the properties of both light scattering and Brownian motion in order to obtain the size distribution and concentration measurement of particles in liquid suspension. A laser beam is passed through the sample chamber, and the particles in suspension in the path of this beam scatter light in such a manner that they can easily be visualized via 20x magnification microscope onto which is mounted a camera. The camera operates at 30 frames per second (fps), capturing a video file of the particles moving under Brownian motion. The software tracks many particles individually and using the Stokes-Einstein equation calculates their hydrodynamic diameters.

More info:  http://www.malvern.com/en/products/product-range/nanosight-range/nanosight-ns300/default.aspx

Technical Specifications:

Wavelength: 405nm (violet), 488nm (blue), 532nm (green) or 642nm (red).

Temperature control range: 5°C below ambient to 55°C.

Stage: Fixed stage.

Focus: Computer controlled motorized focus.

Camera:

Fluorescence: Motorized 6 place filter wheel with choice of filters.

Particle size: 10nm to 2000nm.

Concentration range: 106to 109 particles per mL.

Read More

U6-S14. Quantitative studies of biomolecular interactions by calorimetric measurements (On-site) OUTSTANDING

Quantitative studies of biomolecular interactions by calorimetric measurements

Isothermal Titration Calorimetry (ITC) is a thermodynamic technique that directly measures the heat released or absorbed during a biomolecular binding event (protein-small molecule, protein-protein, target-drug, enzyme-inhibitor, antibody-antigen, protein-DNA, protein-lipid, small molecule-small molecule). Measurement of this heat allows accurate determination of binding constants (KB), reaction stoichiometry (n), enthalpy (ΔH) and entropy (ΔS), thereby providing a complete thermodynamic profile of the molecular interaction in a single experiment. Because ITC goes beyond binding affinities and can elucidate the mechanism of the molecular interaction, it has become the method of choice for characterizing biomolecular interactions.
The equipment used for this purpose is VP-ITC (GE HealthCare-Microcal).

Customer benefits

Applications range goes from drug design to fundamental research, such as understanding and regulating signal transduction pathways. These systems provide direct marker-free and in-solution measurement of binding affinity and thermodynamic parameters in a single experiment. They have high sensitivity, low sample consumption and automation options to minimise handling time.

Target customer

  • Biochemical and Pharmaceutical companies.
  • Biology and biochemistry research groups.

Additional information

M.Köber, et al., Journal of Colloid and Interface Science 631 (2023) 202–211. DOI: 10.1016/j.jcis.2022.10.104

Compra al mejor precio MALVERN MicroCal VP-ITC | Bimedis

Read More

U24-E06. Cardiac electrophysiology lab with navigation (CARTO 3) and biotherapeutics delivery (NOGA XP) systems

Cardiac electrophysiology lab with navigation (CARTO 3) and biotherapeutics delivery (NOGA XP) systems.

Read More

U1-S05. Training courses in protein production (Biomolecules production)

Training courses in protein production (Biomolecules production)

The PPP unit provides personalised training courses in recombinant protein production and purification either at our facilities or at the client’s.
The courses can include practical training sessions, for example, in the use of FPLC-AKTA systems.

Examples of trainings are:

  • “Strategies for optimization of recombinant protein production” Advanced and Initial levels.
  • Theoretical-practical training in the management of the FPLC-AKTA system.

Applications: For users who want to use FPLC-AKTA systems. For staff of biotechonology companies. For students of Ph.D. programs.

Customer benefits

The PPP Unit specialises in designing, producing, and purifying recombinant proteins on demand, tailored to customers‘requirements. We have an extensive expertise in designing different strategies to achieve successfully final products according customers‘ needs. The service is completely personalised to ensure that the training fits the needs of the costumer. The training courses can be made collectively or individually.

Target customer

The PPP Unit extends its services across the scientific community, serving both private and public research organizations. This includes support for research centres, universities, hospitals, and companies in the sector. Leveraging our connection with the university, the PPP unit also provides specialised courses as part of the official master’s degrees and PhD programs at UAB. The training courses can be made collectively or individuality.

Additional information

See morea bout the PhD programme in UAB (link)

Read More

MEMBERS OF THE IBB WILL INVESTIGATE THE EARLY DIAGNOSIS OF PARKINSON

Researchers from the Folding and Conformational Diseases Group at the Institute of Biotechnology and Biomedicine Group are part of the European project Neuromed to develop molecules and detect biomarkers of this disease before the signs of neurodegeneration become evident.

The Neuromed project is led by the University of Zaragoza and aims to design molecules, drugs and new diagnostic tools early for three neurodegenerative diseases in which defective proteins are involved: Parkinson’s disease and two rare diseases, phenylketonuria and protein TTR Amyloidosis.

The coordination of the Parkinson’s research line will be directed, from the IBB, by Salvador Ventura, principal researcher and director the  Protein Folding and Conformational Diseases group and Professor at the Department of Biochemistry and Molecular Biology at the UAB. Researchers in his group are also involved in the project.

The goal of Professor Ventura and his collaborators is focused on developing a diagnostic kit that will allow early and sensitive detection of the presence of Parkinson’s biomarkers in blood and cerebrospinal fluid, in such a way  that the treatment of the disease can begin before the signs of neurodegeneration are obvious.

Neuromed strikes a common element of the three diseases to be investigated: their conformational defects. The research will look for new molecules that can even recover the activity of defective proteins. The combination of computational and biophysical techniques to identify and develop compounds that are tested in cell and animal models would allow the development of drugs active on the three diseases, and will contribute to the early diagnosis of Parkinson.

The Consortium Neuromed involves six partners from Spain, Portugal and France. The research groups, Including the one of professor Ventura, have consolidated expertise in the approach to diagnose and treat these diseases. The project will run for 14 months and has a total cost exceeding EUR 1 million.

Nanbiosis Ibb news
Read More